Skip to main content
profile image
Selected Works of William L. Redmond, PhD
Article
Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC
Journal for ImmunoTherapy of Cancer (2014)
  • Rachel Sanborn, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Brian Boulmay, LSU Health Sciences Center New Orleans
  • Rui Li, Providence Cancer Center, Portland, OR, USA
  • Bradley Spieler, LSU Health Sciences Center New Orleans
  • Kyle Happel, LSU Health Sciences Center New Orleans
  • Christopher Paustian, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Tarsem Mougdil, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Zipei Feng, Earle A. Chiles Research Institute, Portland, OR, USA
  • Christopher Dubay, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Brenda Fisher, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Yoshinobu Koguchi, Earle A. Chiles Research Institute, Portland, OR, USA
  • Sandra Aung, Prometheus Laboratories Inc., San Diego, CA, USA
  • Eileen Mederos, LSU Health Sciences Center New Orleans
  • Carlo Bifulco, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Michael McNamara, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Keith S Bahjat, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • William Redmond, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Augusto C Ochoa, LSU Health Sciences Center New Orleans
  • Hong Ming Hu, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA
  • Bernard Fox, Earle A. Chiles Research Institute, Portland, OR, USA
  • Walter Urba, Earle A. Chiles Research Institute, Portland, OR, USA
  • Traci Hilton, UbiVac, Portland, OR, USA
Link
Disciplines
Publication Date
December 1, 2014
DOI
10.1186/2051-1426-2-S3-P249
Citation Information
Rachel Sanborn, Brian Boulmay, Rui Li, Bradley Spieler, et al.. "Preliminary analysis of immune responses in patients enrolled in a Phase II trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod for adjuvant treatment of Stage IIIA or IIIB NSCLC" Journal for ImmunoTherapy of Cancer Vol. 3 Iss. 3 (2014) p. 435
Available at: http://works.bepress.com/william-redmond/33/